New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
doi 10.22141/2224-0721.4.76.2016.77809
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House Zaslavsky

Related search

What Future for Therapeutic Prevention of Type I (Insulin-Dependent) Diabetes Mellitus?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1992English

Preconceptional Diabetes Control in Insulin-Dependent Diabetes Mellitus Patients With Continuous Subcutaneous Insulin Infusion Therapy

Journal of Perinatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
1987English

Basal-Bolus Insulin Therapy in Postoperative Inpatients With Diabetes Mellitus: Directions for Future Quality-Improvement Initiatives

Future Science OA
MedicineBiotechnology
2018English

The Insulin Treatment of Diabetes Mellitus.

JAMA - Journal of the American Medical Association
Medicine
1925English

Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2016English

HLA-DRB1 Reduces the Risk of Type 2 Diabetes Mellitus by Increased Insulin Secretion

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Indwelling Cannula for Insulin Administration in Diabetes Mellitus.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1991English

Diabetes Mellitus as a Conformational Disease: A Novel Potential Therapeutic Approach

Endocrine Abstracts
2015English

Osteopenia in Insulin Treated Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy